Omkring 40% af patienterne (i hver behandlingsgruppe) fik GPIIb/ IIIa- inhibitorer til støtte for PCI (der er ingen tilgængelig infornmation om den anvendte type af GPIIb/ IIIa- inhibitor).
Approximately 40% of patients (in each of the treatment groups) received GPIIb/ IIIa inhibitors in support of PCI (no information available regarding the type of GP IIb/ IIIa inhibitor used).